| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $41.8M | -22.3% |
| SG&A Expense | $18.7M | -0.1% |
| Operating Income | -$40.5M | +27.7% |
| Interest Expense | $3.1M | — |
| Net Income | -$37.4M | +30.6% |
| EPS (Basic) | -$1.05 | +43.5% |
| EPS (Diluted) | -$1.05 | +43.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.3M | +3.9% |
| Current Assets | $138.4M | -1.3% |
| Total Assets | $174.8M | +9.1% |
| Current Liabilities | $19.4M | -19.2% |
| Long-term Debt | $40.0M | — |
| Total Liabilities | $63.5M | +67.4% |
| Stockholders' Equity | $111.4M | -9.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.6M | +19.7% |
| Capital Expenditures | $769K | -78.7% |
| Investing Cash Flow | -$769K | +78.7% |
| Financing Cash Flow | $58.4M | +267.3% |
| Free Cash Flow | -$33.4M | +24.5% |